Home

Gnezdo Profesionalnost odgovornost hamlet pharma spotlight Eksplicitna pšenice Katastrofa

Horizon 2020 - Hamlet Pharma
Horizon 2020 - Hamlet Pharma

Start-2022 - Hamlet Pharma
Start-2022 - Hamlet Pharma

Hamlet Pharma-BC Kick-off meeting - Hamlet Pharma
Hamlet Pharma-BC Kick-off meeting - Hamlet Pharma

Linnanepharma Organisation
Linnanepharma Organisation

Horizon 2020 - Hamlet Pharma
Horizon 2020 - Hamlet Pharma

About Clinical Trials - Hamlet Pharma
About Clinical Trials - Hamlet Pharma

Start-2022 - Hamlet Pharma
Start-2022 - Hamlet Pharma

Hamlet Pharma AB - Stock and Shares News | IPO HUB
Hamlet Pharma AB - Stock and Shares News | IPO HUB

Start-2022 - Hamlet Pharma
Start-2022 - Hamlet Pharma

Pressmeddelande Archives - Page 4 of 5 - Hamlet Pharma
Pressmeddelande Archives - Page 4 of 5 - Hamlet Pharma

Interim report October – December 2021
Interim report October – December 2021

Media Archive - Hamlet Pharma
Media Archive - Hamlet Pharma

Interim report July–September 2021
Interim report July–September 2021

Horizon 2020 - Hamlet Pharma
Horizon 2020 - Hamlet Pharma

Press Release
Press Release

Horizon 2020 - Hamlet Pharma
Horizon 2020 - Hamlet Pharma

Interim report January – March 2021
Interim report January – March 2021

Horizon 2020 - Hamlet Pharma
Horizon 2020 - Hamlet Pharma

Press Release Hamlet Pharma regains patent rights for BAMLET
Press Release Hamlet Pharma regains patent rights for BAMLET

About Clinical Trials - Hamlet Pharma
About Clinical Trials - Hamlet Pharma

Start-2022 - Hamlet Pharma
Start-2022 - Hamlet Pharma

Start-2022 - Hamlet Pharma
Start-2022 - Hamlet Pharma

Quest for the cure - Hamlet Pharma
Quest for the cure - Hamlet Pharma

Spotlight welcomes ODI Pharma
Spotlight welcomes ODI Pharma

Market Notice 50/21 – Information regarding the split and reclassification  of shares in Hamlet Pharma AB
Market Notice 50/21 – Information regarding the split and reclassification of shares in Hamlet Pharma AB